Rocky River, OH, United States of America

George William Farr

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovations of George William Farr: A Pioneer in Aquaporin Research

Introduction

George William Farr is a notable inventor based in Rocky River, Ohio, with a remarkable portfolio of 11 patents to his name. With a focus on aquaporin inhibitors, Farr's inventions aim to address significant medical challenges related to water imbalance conditions. Her work in this specialized field has implications for the treatment of various diseases, showcasing the impact of her innovations on pharmaceutical advancements.

Latest Patents

Farr's latest patents include innovative prodrug salts that consist of selective aquaporin inhibitors. These novel compounds are designed for use as pharmaceuticals and come with novel pharmaceutical compositions. The synthesis processes and intermediates for these prodrug salts are also highlighted in her patents. The significance of Farr's work lies in the potential applications for the prophylaxis, treatment, and control of multiple aquaporin-mediated conditions, including edema, hyponatremia, and a range of diseases such as epilepsy and myocardial ischemia.

Career Highlights

Farr currently works at Aeromics, Inc., where her expertise in aquaporin research continues to drive innovation. She has been actively contributing to the field with her inventions, focusing on methods that treat or control cytotoxic cerebral edema following ischemic strokes, as well as other complex medical concerns. Her dedication to advancing treatments significantly enhances the therapeutic landscape for patients suffering from water imbalance and related conditions.

Collaborations

Throughout her career, Farr has worked closely with notable colleagues, including Marc F. Pelletier and Paul Robert McGuirk. These collaborations have enriched her research and have helped amplify the impact of her inventions in the scientific community. The synergy between Farr and her coworkers exemplifies the power of teamwork in developing innovative solutions in healthcare.

Conclusion

George William Farr stands out as a leading inventor in the pharmaceutical field, particularly in aquaporin inhibitor research. Her innovative patents not only contribute to medical science but also foster collaboration and advancement in therapeutic solutions. As her work continues to evolve, Farr remains a key figure in addressing complex medical challenges through innovative inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…